BY DR. LLOYD COVENS
Friday, May 31 marked a historic day for CBD, the starting point for a rulemaking on how the FDA will set rules to allow CBD in foods, pet supplements and cosmetics. At the head table, various DC regulators listened to multiple experts during the morning session:
Amy Abernethy, MD, PhD Principal Deputy Commissioner, FDA — Chair
Douglas Throckmorton, MD Deputy Director, Regulatory Programs Center for Drug Evaluation and Research
Nick Alexander, JD Director, Intergovernmental Affairs Office of Policy, Legislation, and International Affairs, FDA
Dayle Cristinzio Director, Stakeholder Engagement Office of External Affairs, FDA
Jarilyn Dupont, JD Director of Regulatory Policy Office of Policy, FDA
Randall Gnatt, JD Regulatory Counsel Center for Veterinary Medicine, FDA
Rebecca Goldberg, JD Associate Chief Counsel Office of the Chief Counsel, FDA
Sharon Mayl, JD Senior Advisor for Policy Office of Foods and Veterinary Medicine, FDA
Erik Mettler, MPA, MPH Asst Commissioner, Partnerships and Policy Office of Regulatory Affairs FDA
Timothy Schell, PhD Director, Office of Surveillance and Compliance Center for Veterinary Medicine, FDA
Lowell Schiller, JD Principal Associate Commissioner for Policy Office of Policy, FDA
Sherene Sepehri, JD Associate Chief Counsel Office of the Chief Counsel, FDA
Steven Tave, JD Director, Office of Dietary Supplement Programs, Center for Food Safety and Applied Nutrition, FDA
During the afternoon session, these key business and pharma witnesses testified.
Bill Grubb Noramco
Deb Kimless Pure Green
Douglas MacKay CV Sciences
Ray Mannion Zynerba Pharmaceuticals, Inc.
Rosemary Mazanet Columbia Care Inc.
Alice Mead Greenwich Biosciences (GW Pharma)
Stephen Mueller Mile High Labs
James Sharkey Therabis, LLC , and
Priyanka Sharma Kazmira LLC
Look for an in-depth report on the day’s events coming soon.
–Based in Denver, Dr. Lloyd Covens, DBA is a seasoned cannabis industry journalist and the publisher of West420 NewsWeekly. Writing his doctorate on diffusion of innovations, Covens has been an expert journalist/researcher for 20 years chronicling new technology, global television and renewable energy advancements. He has reported on developments in the cannabis and hemp industry with weekly reports since 2014 covering the western U.S. for legal medical cannabis, recreational sales and hemp production. Covens is also the creator of the annual CO Hemp CBD conference held in Pueblo, Colorado.